{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+for+Risankizumab+SC", "query": { "intervention": "Placebo for Risankizumab SC" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 11, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+for+Risankizumab+SC&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-29T12:29:18.214Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03398135", "title": "A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ulcerative Colitis (UC)" ], "interventions": [ { "name": "risankizumab", "type": "DRUG" }, { "name": "placebo for risankizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "16 Years to 80 Years" }, "enrollment_count": 1242, "start_date": "2018-08-28", "completion_date": "2029-02", "has_results": false, "last_update_posted_date": "2026-01-20", "last_synced_at": "2026-09-29T12:29:18.214Z", "location_count": 78, "location_summary": "Coronado, California • Irvine, California • La Jolla, California + 60 more", "locations": [ { "city": "Coronado", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Alamitos", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03398135" }, { "nct_id": "NCT03926169", "title": "A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hidradenitis Suppurativa" ], "interventions": [ { "name": "Risankizumab", "type": "DRUG" }, { "name": "Placebo for risankizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 243, "start_date": "2019-06-03", "completion_date": "2021-08-02", "has_results": true, "last_update_posted_date": "2022-08-11", "last_synced_at": "2026-09-29T12:29:18.214Z", "location_count": 22, "location_summary": "Hot Springs, Arkansas • Bakersfield, California • Los Angeles, California + 17 more", "locations": [ { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Bakersfield", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03926169" }, { "nct_id": "NCT03105128", "title": "A Study of the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "placebo for risankizumab", "type": "DRUG" }, { "name": "risankizumab IV", "type": "DRUG" }, { "name": "risankizumab SC", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "16 Years to 80 Years" }, "enrollment_count": 931, "start_date": "2017-05-10", "completion_date": "2021-04-14", "has_results": true, "last_update_posted_date": "2022-07-06", "last_synced_at": "2026-09-29T12:29:18.214Z", "location_count": 117, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • Tempe, Arizona + 94 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03105128" }, { "nct_id": "NCT03671148", "title": "A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriatic Arthritis (PsA)" ], "interventions": [ { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "Risankizumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 444, "start_date": "2019-03-07", "completion_date": "2026-06-04", "has_results": true, "last_update_posted_date": "2026-07-20", "last_synced_at": "2026-09-29T12:29:18.214Z", "location_count": 55, "location_summary": "Anniston, Alabama • Fullerton, California • Huntington Beach, California + 50 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Fullerton", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "La Palma", "state": "California" }, { "city": "San Leandro", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03671148" }, { "nct_id": "NCT03706040", "title": "A Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic Dermatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dermatitis" ], "interventions": [ { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "Risankizumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 172, "start_date": "2018-12-27", "completion_date": "2021-04-26", "has_results": true, "last_update_posted_date": "2021-11-18", "last_synced_at": "2026-09-29T12:29:18.214Z", "location_count": 39, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Anaheim, California + 35 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Fremont", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03706040" }, { "nct_id": "NCT06063967", "title": "A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "Risankizumab SC", "type": "DRUG" }, { "name": "Placebo for risankizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 289, "start_date": "2023-11-15", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2025-09-09", "last_synced_at": "2026-09-29T12:29:18.214Z", "location_count": 79, "location_summary": "Sun City, Arizona • Corona, California • Coronado, California + 65 more", "locations": [ { "city": "Sun City", "state": "Arizona" }, { "city": "Corona", "state": "California" }, { "city": "Coronado", "state": "California" }, { "city": "Covina", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06063967" }, { "nct_id": "NCT03104413", "title": "A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "placebo for risankizumab IV", "type": "DRUG" }, { "name": "risankizumab SC", "type": "DRUG" }, { "name": "risankizumab IV", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "16 Years to 80 Years" }, "enrollment_count": 618, "start_date": "2017-12-18", "completion_date": "2021-05-19", "has_results": true, "last_update_posted_date": "2022-06-14", "last_synced_at": "2026-09-29T12:29:18.214Z", "location_count": 114, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • Tempe, Arizona + 89 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03104413" }, { "nct_id": "NCT03398148", "title": "A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Ulcerative Colitis (UC)" ], "interventions": [ { "name": "risankizumab IV", "type": "DRUG" }, { "name": "placebo for risankizumab", "type": "DRUG" }, { "name": "risankizumab SC", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "16 Years to 80 Years" }, "enrollment_count": 1558, "start_date": "2018-03-07", "completion_date": "2023-05-11", "has_results": true, "last_update_posted_date": "2025-01-16", "last_synced_at": "2026-09-29T12:29:18.214Z", "location_count": 82, "location_summary": "Coronado, California • Irvine, California • La Jolla, California + 63 more", "locations": [ { "city": "Coronado", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Alamitos", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03398148" }, { "nct_id": "NCT03105102", "title": "A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "Placebo for Risankizumab SC", "type": "DRUG" }, { "name": "Risankizumab IV", "type": "DRUG" }, { "name": "Placebo for Risankizumab IV", "type": "DRUG" }, { "name": "Risankizumab SC", "type": "DRUG" }, { "name": "Risankizumab On-Body Injector (OBI)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "16 Years to 80 Years" }, "enrollment_count": 1336, "start_date": "2018-04-09", "completion_date": "2029-02", "has_results": false, "last_update_posted_date": "2026-08-14", "last_synced_at": "2026-09-29T12:29:18.214Z", "location_count": 111, "location_summary": "Mesa, Arizona • Phoenix, Arizona • Tucson, Arizona + 91 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Coronado", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03105102" }, { "nct_id": "NCT03875482", "title": "A Study to Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "Risankizumab", "type": "DRUG" }, { "name": "Placebo solution for risankizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 157, "start_date": "2019-05-13", "completion_date": "2020-07-15", "has_results": true, "last_update_posted_date": "2021-03-16", "last_synced_at": "2026-09-29T12:29:18.214Z", "location_count": 40, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Rogers, Arkansas + 35 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Beverly Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03875482" } ] }